Moneycontrol
you are here: HomeNewsBusinessIPO
Last Updated : Dec 04, 2017 09:12 PM IST | Source: PTI

Shalby garners Rs 150 crore from anchor investors

The company's IPO committee has finalised allocation of 60,70,150 equity shares to 11 anchor investors at Rs 248 apiece, also the upper price band for the offer, Shalby informed to the stock exchanges.

Ahmedabad-based multi-specialty hospital chain Shalby Ltd on Monday raised over Rs 150 crore from anchor investors, ahead of its initial share-sale, which opens on Tuesday.

The company's IPO committee has finalised allocation of 60,70,150 equity shares to 11 anchor investors at Rs 248 apiece, also the upper price band for the offer, Shalby informed to the stock exchanges.

At this price, the total amount works out to be Rs 150.54 crore, it added.

Among the anchor investors are Goldman Sachs, Citigroup, Reliance Nippon Life Insurance Company, Nomura and SBI Life Insurance Company.

ALSO READ: Shalby IPO to open on December 5; 10 things you should know before investing

Shalby's initial public offer (IPO) will open for public subscription tomorrow and close on December 7.

The IPO comprises a fresh issue of equity shares aggregating up to Rs 480 crore and an offer for sale of up to 10 lakh equity shares by the selling shareholder.

The price band has been fixed at Rs 245-248 per share. At the upper end, the public issue would fetch Rs 504 crore.

Proceeds of the IPO will be utilised towards repayment of borrowings availed by the company besides purchasing medical equipment for existing, recently set-up as well as upcoming hospitals.

In the recent months, healthcare services firms Alkem Laboratories, Dr Lal Pathlabs, Narayana Hrudayalaya, Thyrocare and Eris Lifesciences have tapped the primary market through IPO route.
First Published on Dec 4, 2017 08:38 pm
More From
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant